"Our data demonstrate that designer methcathinone analogs are substrates for monoamine transporters, with a profile of transmitter-releasing activity comparable to 3,4-methylenedioxymethamphetamine (MDMA, or 'ecstasy')," wrote NIDA researchers in the online December 14 Neuropsychopharmacology. "Given the widespread use of mephedrone and methylone, determining the consequences of repeated drug exposure warrants further study," they said.
Read more about "bath salts" in Psychiatric News.
(Image: Psychiatric News)